Keywords
Pediatric asthma
Immune index
Submitted : 2024-04-10
Accepted : 2024-04-25
Published : 2024-05-10
Abstract
Objective: To explore and analyze the effect of nebulized budesonide inhalation on children with asthma and its influence on immune indexes. Methods: 300 children who were with asthma admitted to the Pediatric Respiratory Department of our hospital from January 2021 to January 2023 were selected as the research subjects. The patients were divided into a nebulization group (n = 150) and a reference group (n = 150) by drawing lots. The nebulization group received routine treatment along with budesonide nebulization inhalation therapy, while the reference group only received routine treatment. The treatment effect, the immune indicators, the time taken for the disappearance of symptoms, and the pulmonary function indicators of both groups were compared. Results: The total efficacy of treatment received in the nebulization group was significantly higher than that in the reference group (P < 0.05). Before treatment, there was no statistically significant difference in the CD4+, CD8+, CD4+/CD8+, between the two groups (P > 0.05); after treatment, the nebulization group’s CD4+, CD8+, CD4+/CD8+ and other immune indicators were significantly better than the reference group (P < 0.05). The time taken for the disappearance of symptoms like wheezing, coughing, crackles, shortness of breath, and other symptoms in the nebulization group was significantly shorter than in the reference group (P < 0.05). Before treatment, there was no statistically significant difference in the pulmonary function indexes such as FEV1, PEF, and FVC between the two groups (P > 0.05); after treatment, the pulmonary function indexes of the patients in the nebulization group were significantly better than those in the reference group (P < 0.05). Conclusion: Nebulized budesonide inhalation therapy has shown significant efficacy in the treatment of pediatric asthma, with notable improvements in immune indicators. Therefore, it is worthy of recommendation and further promotion
References
Zhao X, 2023, Comparison of Clinical Effect and Safety of Nebulized Inhalation of Budesonide Suspension in Different Doses in the Treatment of Acute Asthma Attack in Children. Clinical Rational Drug Use, 16(11): 27–30.
Liu C, 2022, The curative effect of Ventolin Combined with Pulmicort Oxygen Nebulization Inhalation in Treating Children with Asthma and its Influence on Adverse Reactions and Pulmonary Function. Chinese Medicine Guide, 20(34): 97–99.
Chen W, Chen X, 2022, Clinical Efficacy of Nebulized Inhalation of Montelukast Sodium Combined with Budesonide in Treating Asthma and its Influence on Pulmonary Function and Inflammatory Factors in Children. Journal of Clinical Rational Drug Use, 15(32): 130–132.
Zhang L, Huang J, 2022, Efficacy of Budesonide Combined with Salbutamol in Treating Children with Asthma Complicated by Respiratory Virus Infection and Its Impact on Lung Function. Chinese Practical Medicine, 17(18): 15–19.
Cun Y, Li Q, Wang J, 2022, The Clinical Effect of Ipratropium Bromide Combined with Budesonide Atomized Inhalation in the Treatment of Children with Asthma and its Influence on the Pulmonary Function of Children. Clinical Medicine Research and Practice, 7(12): 32–35.
Song Y, Zhang L, Guo Z, 2022, Analysis of the Clinical Efficacy of Montelukast Combined with Budesonide Assisted Aerosol Inhalation in Treating Children with Asthma Complicated by Respiratory Virus Infection and the Influence on Serum Indicators. Journal of Mathematics and Medicine, 35(04): 554–556.
Zhang X, 2022, Clinical Efficacy of Inhalation of Cetirizine Combined with Budesonide in the Treatment of Children with Acute Exacerbation of Asthma and its Effect on Immune Function. Journal of Clinical Rational Drug Use, 15(09): 150–152.
Zuo Z, Li N, 2022, The Clinical Effect of Oral Cetirizine Combined with Inhalation of Budesonide In Treating Children with Acute Asthma Attacks and its Influence On The Level of Inflammatory Factors in Children. Clinical Medicine Research and Practice, 7(09): 94–97.
Yi L, Che E, 2022, The Clinical Efficacy of Nebulized Albuterol Inhalation Combined with Montelukast in Treating Children with Acute Asthma Attacks and its Influence on Lung Function and T Lymphocyte Subsets in Children. Jilin Medicine, 43(03): 719–720.
Feng X, Qiu J, Yan D, 2021, The Effectiveness of Montelukast Combined with Budesonide in Treating Airway Response and Asthma Attack in Children with Asthma in Remission Period. Journal of Clinical Rational Drug Use, 14(20): 36–38.
Feng Z, 2021, Efficacy of Montelukast Sodium Combined with Budesonide Nebulizer in Treating Children with Asthma and Its Effect on Serum CRP, TNF-?, IL-6. Chinese Modern Drug Application, 15(10): 17–20.
Yuan J, Huang W, Guo S, 2021, Efficacy of Budesonide Suspension Inhaled by Oxygen Drive Nebulization in Treatment of Acute Attack of Infantile Asthma and Its Effect on Pulmonary Function. Chinese Prescription Drugs, 19(05): 116–118.
Shao J, Wang X, 2021, The Clinical Curative Effect of Montelukast Combined with Salmeterol-Timezone Powder Inhalation in Treating Children with Asthma and its Influence on Inflammatory Factors. Journal of Clinical Rational Drug Use, 14(09): 18–20.
Wang L, 2021, Singulair Combined with Budesonide Nebulized Inhalation’s Effect in Treating Children with Asthma and the Analysis of its Impact on Immune Indicators and Pro-Inflammatory Factors. Chinese Modern DrugApplication, 15(04): 172–174.
Zhou R, Zhang W, Chen B, et al., 2020, Clinical Efficacy of Montelukast Sodium Combined with Pulmicort Reswell in Treating Children with an Acute Asthma Attack and its Effect on Serum IL-17, TNF-?, hs-CRP. Laboratory Medicine and Clinic, 17(23): 3515–3517.